Where do I start. Lots of major resistance on route to 13.15. Similarly, Lots of major supports sub 12.44 close. So where's the stock going to go? I want to mention first and foremost, I'm not god people! I get more right than i get wrong and that makes me a winner. I too, want to help those out, so we can all bask in the glory! Today, the stock closed nearing the day high, always a good sign for tomorrows open, expect a smaller but positive gap up. We have major supports (I'll just mention the two closest to 12.44 ps) 12.36/12.38.
Similarly, we have major resistance at 12.45 / 12.50 ps. An open, above 12.50 ps would be what we want. Because, the next major resistance is 12.65 / 12.92. I want to stress, a move above 12.92 ps will likely bring us one step closer to 13.15, as resistance past this point is meager in nature. A move above 13.15 at any point in the day, would indicate a HUGE buying opportunity and price swing to 15$ ps. Again, there's a lot of resistance on route to 13.15.
Simply, put, if investor sentiment is bullish in nature OR an announcement is made from Aphria 3.78%that has substance, there's not doubt in my mind, we will hit 15$ ps within the next two weeks. On too the charts. ALMOST everything looks fantastic! CRSI is positive but a short term pull back is likely ( BULLISH IN NATURE) higher highs and higher lows. RI -1.20% is in extreme bullish territory, stoch RSI is oh so very close to moving into extreme bullish territory, OBV - Volume needs to sustain above averages to sustain bull run,
NOW THIS ONE IS MY FAVORITE! MACD cross likely to happen tomorrow, (thought it would of happened today! I was wrong) A MACD cross would help to propel this stock to 15$. TSX Supports positive momentum, new highs reached (higher highs/Higher lows) this will allow for continued positive momentum. Simply put,
NOTHING IS GOING TO SLOW THIS STOCK DOWN, OTHER THAN ANOTHER BOUGHT DEAL OR INSIDER SELLING. BOTH ARE HIGHLY UNLIKELY BASED ON PRICE POINT! SO, LIKE ALWAYS ENJOY THE RIDE TO 15$. TOMORROW WILL BE INTERESTING!( Thursday June 21 2018)
Indicators show - 18 EXT. Bullishness/20 Bull / 11 Neutral / 5 Bearish . / 0 EXT. Bearishness.
Green day tomorrow. I've stopped giving price estimates, too many people are upset over my ranges (I'm sorry, I can't predict investor sentiment, its an unknown)
If you care to think, what I believe tomorrows close will be, My guess is 12.92 ps or 13.42$ ps
Lookin' Good People - Decent Close - Expect a Gap up! by isnarain on TradingView.com
Thursday, June 21, 2018
Stochastic Prediction Check Out The Chart
Aphria Worldwide Distribution NOT just Canada
As Canada comes close to legalizing recreational marijuana, cannabis stocks have witnessed a sudden surge in their valuation. Despite the vast upside opportunity for pot stocks, the opening up of the recreational marijuana market may be faced with regulatory hardships, just like the tobacco industry.
However, the investors seem to be positive about these stocks, hoping these stocks replicate the growth trajectory of tobacco stocks, such as Philip Morris and Altria. This trend has been witnessed lately with Aphria Inc., (TSX:APH), a low cost of producer of medicinal marijuana in Canada, gaining momentum over the last one month.
In our previous analysis – Here’s Why We Believe That Medical Marijuana Stock Aphria Is Undervalued – we had talked about how we think that Aphria is undervalued compared to its peers based on a Price/Sales multiple basis. In this note, we aim to discuss the key driver that will drive its value going forward. You can view our valuation for the company on our interactive dashboard and create scenarios to suit your assumptions.
International Expansion Will Drive Top Line Growth
Australia
As more and more companies are legalizing the medical use of marijuana, Aphria has aggressively entered into partnerships and joint ventures to supply its output to these international markets in the last couple of months. For instance, the Canadian company completed its first shipment of medical cannabis to its Australia-based partner Althea in late April of this year. The initial shipment, which is the first of the four shipments due in the next 12 months, included a mix of cannabis oil products and dried flower, which will be distributed to pharmacies for eligible medical cannabis patients in Australia. Australia serves to be a strategic market for Aphria and its branded cannabis products, and is expected to bolster its sales in the coming months.
Africa
Apart from Australia, Aphria also has plans to capture the South African market, since it has a vast potential for growth in the long term. Consequently, the company entered into a joint venture with South African company Verve Group of Companies to form a new entity known as CannInvest Africa Ltd. The newly formed entity will acquire an interest in Verve Dynamics (Verve), which is a licensed producer of medical cannabis extracts in Lesotho, for a sum of CAD 4.05 million. With Verve Group’s resources and Aphria’s expertise and low cost of production, Verve will be able to supply high-grade low-cost cannabis isolates throughout the African continent and to markets across the globe using Aphria’s international distribution network. Wider reach in newer markets will boost Verve’s revenue and, in turn, complement Aphria’s valuation.
Subscribe to:
Posts (Atom)
Posts
